↑ トップへ ← 戻る

 Drug(薬物リスト) DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

104 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   0.5% marcaine   -   -   -   -   1件:
70 
 2   0.9% saline   -   -   -   -   1件:
70 
 3   0002-8971   -   -   -   -   1件:
70 
 4   1mg/kg/hr txa intravenous infusion till the last suture   -   -   -   -   1件:
70 
 5   Acetaminophen   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   11件:
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271 
 6   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 7   Allogen-li   -   -   -   -   1件:
70 
 8   Alprostadil   Alprostadil   D00180, D02705   1件: PTGER1   4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer   2件:
51,
70 
 9   Amino acids   Amino acids   -   -   -   4件:
70,
90,
240,
298 
 10   Aminocaproic acid   Aminocaproic acid   D00160   1件: PLG   4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection   1件:
70 
 11   Bilateral transforaminal epidural steroid injections   -   -   -   -   1件:
70 
 12   Botulinum toxin type a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   10件:
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 13   Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   1件:
70 
 14   Bupivacaine   Bupivacaine   D01450, D07552   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   7件:
46,
53,
70,
96,
168,
226,
298 
 15   Buprenorphine   Buprenorphine   D00836, D07132   2件: OPRK1, OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   2件:
46,
70 
 16   Caudal epidural injection   -   -   -   -   1件:
70 
 17   Caudal epidural injection with celestone   -   -   -   -   1件:
70 
 18   Caudal epidural injection with depomedrol   -   -   -   -   1件:
70 
 19   Caudal epidural injection with generic celestone   -   -   -   -   1件:
70 
 20   Celebrex 200mg capsule   -   -   -   -   1件:
70 
 21   Celecoxib   Celecoxib   D00567   1件: PTGS2   20件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   8件:
2,
3,
34,
46,
70,
89,
161,
271 
 22   Cilostazol   Cilostazol   D01896   3件: PDE3A, PDE3B, TBXA2R   14件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
51,
70 
 23   Control group   -   -   -   -   2件:
46,
70 
 24   Darvocet   -   -   -   -   1件:
70 
 25   Decadron phosphate, injectable   Phosphate ion   -   -   -   1件:
70 
 26   Deksmedetomidiini   -   -   -   -   1件:
70 
 27   Demineralized bone matrix   -   -   -   -   1件:
70 
 28   Depomedrol   -   -   -   -   1件:
70 
 29   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 30   Dexdor   -   -   -   -   4件:
2,
4,
6,
70 
 31   Dexmedetomidine   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 32   Dexmedetomidine group   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
70 
 33   Dexmedetomidine hydrochloride   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
70 
 34   Diphenhydramine   Diphenhydramine   D00300, D00669, D02419, D03285, D03360, D03854   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   5件:
49,
51,
70,
86,
256 
 35   Eaca   Aminocaproic acid   D00160   1件: PLG   4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection   1件:
70 
 36   Epidural injection   -   -   -   -   1件:
70 
 37   Epidural local anesthetic injection   -   -   -   -   1件:
70 
 38   Epidural steroid injection   -   -   -   -   1件:
70 
 39   Epsilon-aminocaproic acid (eaca)   Aminocaproic acid   D00160   1件: PLG   4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection   1件:
70 
 40   Erythropoietin   Erythropoietin   D03231   1件: EPOR   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   8件:
2,
6,
13,
22,
47,
70,
95,
96 
 41   Esketamine   Esketamine   D07283   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   3件:
2,
4,
70 
 42   Esketamine hydrochloride   Esketamine   D07283   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
70 
 43   Fentanyl   Fentanyl   D00320, D01399   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   5件:
46,
70,
85,
215,
231 
 44   Forsteo   -   -   -   -   3件:
70,
235,
274 
 45   Forteo   Teriparatide   D06078   1件: PTH1R   3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action   1件:
70 
 46   Gabapentin   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   5件:
6,
13,
19,
70,
298 
 47   Heparin   Heparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   11件:
60,
70,
79,
84,
107,
224,
226,
280,
299,
316,
317 
 48   Herbal medicine   -   -   -   -   1件:
70 
 49   Hyaluronic acid   Hyaluronic acid   D08043   -   -   5件:
46,
53,
70,
226,
231 
 50   I-factor   -   -   -   -   1件:
70 
 51   Kenalog injectable product   -   -   -   -   1件:
70 
 52   Ketamine   Ketamine   D00711, D08098   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   5件:
13,
70,
113,
156,
215 
 53   Ketanest-s   -   -   -   -   3件:
2,
4,
70 
 54   Ketorolac   Ketorolac   D00813, D08104   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   2件:
70,
226 
 55   Limaprost   Limaprost   D02722   1件: PTGER1   4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer   1件:
70 
 56   Liposomal bupivacaine   Bupivacaine   D01450, D07552   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   2件:
70,
96 
 57   Lumbar interbody fusion with autograft   -   -   -   -   1件:
70 
 58   Lumbar interbody fusion with neofuse   -   -   -   -   1件:
70 
 59   Midazolam   Midazolam   D00550, D00696, D05028   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   10件:
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 60   Monitor   Methamidophos   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300 
 61   Morphine   Morphine   D00842, D02271, D08233   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   4件:
36,
46,
70,
86 
 62   Morphine pca   Morphine   D00842, D02271, D08233   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   1件:
70 
 63   Neofuse   -   -   -   -   1件:
70 
 64   Nicardipine   Nicardipine   D00617, D08270   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   34件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
70,
86 
 65   Ns-304   -   -   -   -   3件:
70,
86,
88 
 66   Ns-304 placebo   -   -   -   -   2件:
70,
88 
 67   Nsaids   -   -   -   -   4件:
46,
70,
107,
271 
 68   Nucel   -   -   -   -   1件:
70 
 69   Nucel with autograft   -   -   -   -   1件:
70 
 70   Oksikodoni   -   -   -   -   1件:
70 
 71   Opana   Oxymorphone   D08323   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   1件:
70 
 72   Oxanest   -   -   -   -   1件:
70 
 73   Oxycodone   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   7件:
6,
13,
46,
70,
226,
231,
298 
 74   Oxycodone hydrochloride   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   3件:
70,
226,
298 
 75   Oxycodone orion   Oxycodone   D03783, D05312, D05462   3件: OPRD1, OPRK1, OPRM1   5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   1件:
70 
 76   Oxygen   Oxygen   D00003   -   -   14件:
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 77   Parathyroid hormone   Parathyroid hormone   D05364   2件: PTH1R, PTH2R   3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action   2件:
70,
235 
 78   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 79   Predinose oral   -   -   -   -   1件:
70 
 80   Pregabalin   Pregabalin   D02716   4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4   7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway   5件:
13,
36,
46,
70,
298 
 81   Pregabalin 75mg   Pregabalin   D02716   4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4   7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway   1件:
70 
 82   Prolotherapy solution of 20% dextrose   -   -   -   -   1件:
70 
 83   Remifentanil   Remifentanil   D01177, D08473   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   2件:
6,
70 
 84   Rhpth   Parathyroid hormone   D05364   2件: PTH1R, PTH2R   3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action   3件:
70,
235,
326 
 85   Rhpth (1-34)   Parathyroid hormone   D05364   2件: PTH1R, PTH2R   3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action   1件:
70 
 86   Ropivacaine   Ropivacaine   D04048, D08490   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   3件:
36,
46,
70 
 87   S-ketamine   Ketamine   D00711, D08098   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
70 
 88   S-ketamine & midazolam   Midazolam   D00550, D00696, D05028   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
70 
 89   Selexipag   Selexipag   D09994   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   5件:
51,
70,
84,
86,
88 
 90   Sugar pill   -   -   -   -   7件:
6,
49,
67,
70,
86,
206,
226 
 91   Teriparatide   Teriparatide   D06078   1件: PTH1R   3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action   6件:
46,
68,
70,
71,
235,
274 
 92   Teriparatide [rdna origin] contains recombinant human parathyroid hormone (1-34)   Parathyroid hormone   D05364   2件: PTH1R, PTH2R   3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action   1件:
70 
 93   Titanium   Titanium   -   -   -   2件:
69,
70 
 94   Tramadol   Tramadol   D01355, D08623   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   5件:
46,
70,
78,
226,
271 
 95   Tranexamic acid   Tranexamic acid   D01136   1件: PLG   4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection   5件:
46,
70,
215,
227,
288 
 96   Tranexamic acid 100 mg/ml   Tranexamic acid   D01136   1件: PLG   4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection   1件:
70 
 97   Transdermal fentanyl matrix, gabapentin   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   1件:
70 
 98   Triamcinolone   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
35,
46,
56,
70,
90,
96,
226,
298 
 99   Triamcinolone acetonide and normal saline solution   Triamcinolone   D00385, D00983, D00984, D00985, D06216   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
70 
 100   Vancomycin   Vancomycin   D00212, D00926   -   -   7件:
46,
70,
94,
96,
97,
296,
299 
 101   Vivigen cellular bone matrix   -   -   -   -   1件:
70 
 102   With u-vanco (vancomycin hydrochloride)   Vancomycin   D00212, D00926   -   -   1件:
70 
 103   Without u-vanco (vancomycin hydrochloride)   Vancomycin   D00212, D00926   -   -   1件:
70 
 104   Wound topically irrigated with 500mg txa   -   -   -   -   1件:
70 

先頭へ